wheezi
lower
respiratori
tract
ill
wlri
common
earli
childhood
often
associ
respiratori
virus
particularli
respiratori
syncyti
viru
rsv
rsvassoci
wlri
repres
common
caus
hospit
among
infant
firstworld
countri
relationship
earli
wheez
subsequ
develop
asthma
controversi
one
hand
clear
although
wheez
infanc
common
episod
often
transient
natur
popul
basi
associ
asthma
later
life
howev
numer
studi
report
associ
sever
rsv
bronchiol
earli
childhood
recurr
wheez
asthma
later
childhood
unclear
relationship
occur
children
popul
larg
relationship
earli
childhood
rsv
infect
atop
sensit
equal
controversi
publish
studi
avail
argu
either
causal
relationship
earli
infect
subsequ
atopi
addit
accumul
evid
suggest
suscept
viral
infect
atopi
may
deriv
common
set
transient
development
defect
cellular
immun
function
oper
earli
infanc
complic
consider
causal
versu
consequenti
interact
diseas
process
impact
asthma
develop
also
becom
increasingli
evid
virus
rsv
need
consid
context
asthma
atopi
pathogenesi
earli
life
notabl
human
rhinovirus
commonli
identifi
viru
involv
uncompl
acut
respiratori
infect
ari
asthma
exacerb
older
children
adult
yet
role
lower
respiratori
pathogen
infant
frequent
disput
children
experienc
lri
secondari
rhinoviru
infect
regard
particular
risk
underli
respiratori
condit
asthma
cystic
fibrosi
cardiorespiratori
problem
recent
lemansk
et
al
infanc
signific
risk
factor
preschool
wheez
popul
highrisk
children
recent
complet
followup
communitybas
cohort
children
high
risk
atopi
document
occurr
sever
viral
ari
infanc
subject
identifi
specif
viral
pathogen
respons
infecti
episod
determin
natur
associ
factor
subsequ
develop
persist
wheez
current
asthma
year
age
previous
report
synergist
interact
atop
sensit
recurr
respiratori
infect
earli
life
risk
asthma
therefor
hypothesis
risk
would
confer
sensit
earli
life
rather
later
sensit
prospect
cohort
children
high
risk
atopi
least
parent
doctordiagnos
histori
hay
fever
asthma
eczema
recruit
prenat
birth
cohort
previous
describ
parent
kept
daili
symptom
diari
record
presenc
symptom
ari
runnyblock
nose
cough
wheez
well
presenc
fever
child
develop
symptom
studi
center
contact
within
hour
home
visit
arrang
within
hour
collect
nasopharyng
aspir
npa
sampl
method
collect
npa
sampl
includ
electron
repositori
detail
inform
episod
ari
durat
fever
runni
nose
cough
wheez
obtain
home
visit
obtain
followup
telephon
call
everi
week
resolut
child
symptom
npa
sampl
frozen
store
futur
analysi
two
control
npa
sampl
one
winter
second
summer
also
collect
child
child
well
free
respiratori
symptom
least
week
npa
sampl
analyz
panel
revers
transcriptas
polymeras
chain
reaction
rhinovirus
picornavirus
coxsacki
echo
enterovirus
coronavirus
rsv
influenza
b
parainfluenza
virus
adenovirus
human
metapneumoviru
chlamydia
pneumonia
mycoplasma
pneumonia
addit
detail
viral
identif
analysi
includ
electron
repositori
children
underw
skin
prick
test
spt
month
year
year
age
panel
allergen
fresh
cow
milk
egg
white
rye
grass
alternaria
aspergillu
hous
dust
mite
cat
dander
histamin
use
posit
control
normal
salin
neg
control
wheal
size
read
minut
wheal
size
mm
test
perform
month
year
mm
year
greater
salin
control
consid
posit
reaction
spt
perform
parent
panel
allergen
wheal
size
mm
consid
posit
studi
doctor
use
inform
collect
followup
telephon
contact
well
diari
card
classifi
episod
ari
follow
episod
runnyblock
nose
cough
absenc
respiratori
symptom
tachypnoea
difficulti
breath
wheez
rattli
chest
classifi
upper
respiratori
ill
episod
associ
wheez
rattli
chest
andor
evid
respiratori
distress
consid
lri
rattlerattli
chest
defin
moist
wet
noisi
breath
sound
child
chest
wheez
defin
highpitch
whistl
sound
heard
come
chest
expir
lri
classifi
wlri
nonwheezi
lri
base
presenc
wheez
report
parent
famili
doctor
asthma
doctor
diagnosi
asthma
ever
year
current
asthma
asthma
wheez
month
visit
transient
wheez
wheez
episod
first
year
life
lateonset
wheez
wheez
year
age
wheez
year
persist
wheez
wheez
first
year
well
wheez
year
current
wheez
wheez
month
visit
data
tabul
analyz
use
spss
version
spss
inc
chicago
ill
x
test
use
estim
odd
ratio
or
ci
categor
variabl
p
consid
signific
associ
logist
regress
analysi
use
calcul
adjust
or
ci
approv
studi
obtain
ethic
committe
king
edward
memori
princess
margaret
hospit
western
australia
fulli
inform
parent
consent
obtain
subject
total
children
recruit
studi
remain
first
year
follow
full
year
studi
children
exclud
withdrew
studi
within
first
month
studi
common
reason
withdraw
movetransf
away
western
australia
signific
differ
found
preval
wheez
first
year
atop
statu
spt
perform
month
children
complet
full
followup
compar
cohort
high
risk
atopi
mother
father
atop
half
biparent
atopi
male
preponder
exist
boy
compris
cohort
approxim
half
children
first
born
live
household
pet
commonli
dog
attend
daycar
first
year
life
expos
environment
tobacco
smoke
breastf
month
overal
cohort
atop
defin
posit
spt
result
least
allergen
time
point
test
month
year
year
seventi
children
never
wheez
first
year
life
sixtyeight
found
transient
wheez
lateonset
wheezer
persist
wheezer
fiftythre
current
wheez
outcom
age
thirtyseven
current
asthma
year
total
episod
ari
report
first
year
classifi
uri
nonwheezi
lri
wlri
approxim
half
infant
uri
least
nonwheezi
lri
first
year
almost
third
cohort
least
wlri
infanc
see
tabl
articl
onlin
repositori
wwwjacionlineorg
presenc
atopi
influenc
number
ari
uri
lri
report
first
year
adjust
confound
effect
gender
older
sibl
daycar
attend
pet
ownership
environment
tobacco
smoke
exposur
parent
histori
asthma
signific
differ
found
number
uri
p
nonwheezi
lri
p
wlri
p
experienc
children
atop
year
compar
nonatop
children
see
tabl
articl
onlin
repositori
wwwjacionlineorg
differ
found
number
febril
ari
experienc
nonatop
versu
atop
children
p
result
previous
publish
includ
complet
sixtynin
percent
npa
specimen
collect
ari
episod
posit
least
viru
rhinovirus
commonli
detect
follow
rsv
tabl
percentag
specimen
test
posit
viru
similar
uri
nonwheezi
lri
wlri
febril
lri
tabl
twentyfour
percent
control
specimen
collect
children
free
respiratori
symptom
viru
posit
rhinoviru
detect
rsv
sampl
tabl
although
rhinoviru
isol
common
rsv
infecti
npa
higher
proport
rsv
infect
display
evid
spread
lower
respiratori
tract
vs
rhinoviru
p
higher
proport
rsv
infect
result
wheez
andor
febril
reaction
vs
rhinoviru
p
wheezi
lri
posit
isol
rhinoviru
rsv
significantli
associ
wheez
outcom
age
year
tabl
ii
associ
confirm
current
wheez
persist
wheez
adjust
gender
older
sibl
environment
tobacco
smoke
exposur
breastfeed
daycar
attend
parent
asthma
although
wlri
posit
isol
rhinoviru
rsv
found
associ
current
asthma
reach
statist
signific
rhinovirusposit
wlri
tabl
ii
predictor
current
asthma
current
wheez
year
accord
age
atop
sensit
within
popul
larg
increas
risk
wheez
persist
age
year
associ
sensit
age
ci
p
outcom
age
ci
p
tabl
iii
signific
associ
also
found
type
ari
first
year
current
wheez
year
tabl
iii
predictor
includ
febril
wlri
wlri
associ
rhinoviru
rsv
wlri
associ
rhinoviru
although
trend
found
current
wheez
associ
wlri
associ
rsv
associ
fail
reach
statist
signific
ci
p
tabl
iii
associ
risk
current
wheez
increas
number
wlri
associ
howev
found
children
atop
age
year
tabl
iii
similarli
signific
predictor
current
asthma
year
wlri
ci
p
febril
lri
ci
p
wheezi
febril
lri
ci
p
rhinoviru
rsv
associ
wlri
ci
p
associ
remain
adjust
gender
parent
atop
diseas
pet
ownership
older
sibl
environment
smoke
exposur
daycar
attend
rhinoviru
rsv
infect
consid
separ
posit
associ
exist
current
asthma
year
rsvassoci
wlri
ci
p
well
current
asthma
rhinovirusassoci
wlri
ci
p
associ
howev
longer
signific
adjust
confound
result
current
studi
cohort
children
high
risk
atopi
demonstr
signific
associ
rhinovirusinduc
rsvinduc
wlri
first
year
life
subsequ
develop
persist
wheez
year
signific
associ
also
observ
rhinovirusinduc
wlri
first
year
life
current
asthma
year
find
found
attribut
children
sensit
earli
make
studi
uniqu
commun
studi
first
one
report
ascertain
viral
etiolog
respiratori
ill
occur
first
year
life
relat
persist
wheez
current
asthma
year
age
moreov
studi
first
one
address
issu
potenti
differ
suscept
viralinduc
wheez
asthma
within
pediatr
popul
uniformli
high
risk
atopi
compar
children
versu
develop
sensit
infanc
wheez
common
cohort
children
current
studi
never
wheez
first
year
life
addit
transient
wheezer
lateonset
persist
wheezer
contrast
martinez
et
al
report
communitybas
cohort
never
wheez
lateonset
wheez
persist
wheez
like
atop
higher
preval
lateonset
persist
wheez
studi
compar
lateonset
persist
wheez
tucson
cohort
surpris
children
select
basi
high
genet
predisposit
atopi
infant
wheez
requir
hospit
shown
risk
factor
asthma
persist
wheez
first
decad
life
work
focus
role
rsv
use
popul
compris
hospitalis
children
children
close
commun
although
import
rsv
caus
sever
respiratori
infect
infanc
undisput
studi
look
longterm
sequela
lri
caus
respiratori
virus
includ
rhinovirus
notabl
except
recent
studi
lemansk
et
al
found
signific
risk
factor
preschool
wheez
symptomat
rhinoviru
ill
infanc
evalu
wheez
year
age
like
mani
children
belong
group
transient
wheezer
previous
describ
less
half
like
persist
wheez
asthma
later
life
children
hospit
rhinovirusassoci
wlri
also
report
increas
risk
asthma
year
age
latter
studi
also
report
children
atop
dermat
like
wheez
rhinoviru
infect
rais
possibl
children
may
like
wheez
time
infect
underli
atop
chang
preexist
airway
current
studi
also
found
signific
associ
rhinovirusassoci
wlri
first
year
life
current
asthma
current
wheez
year
persist
wheez
confirm
import
consid
virus
rsv
determin
viral
contribut
develop
persist
asthma
childhood
relationship
respiratori
infect
induct
asthma
persist
wheez
complex
like
involv
interact
host
factor
age
stage
develop
innat
adapt
immun
mechan
time
infect
pathogen
factor
number
sever
infect
factor
relat
immun
matur
seem
particularli
relev
context
notabl
recent
evid
suggest
resist
viral
infect
atop
sensit
depend
overlap
seri
immun
mechan
strongli
development
regul
consequ
attenu
earli
life
particular
among
children
high
atop
risk
moreov
viral
infect
gener
rsv
infect
particular
hypothes
capabl
modul
function
immun
mechan
postnat
matur
thu
degre
atop
risk
determin
suscept
viral
infect
versu
viral
infect
drive
sensit
importantli
appar
overlap
process
interact
context
asthma
develop
earli
life
yet
resolv
one
aspect
studi
contribut
import
new
insight
issu
follow
previou
cohort
studi
provid
strongest
statist
support
caus
role
cumul
potenti
synergist
effect
infectioninduc
atopyinduc
airway
inflamm
etiolog
persist
asthma
childhood
suffer
limit
lack
inform
time
atop
sensit
among
respect
studi
group
case
studi
reli
assess
atopi
statu
outcom
age
year
sever
year
beyond
peak
period
respiratori
viral
infect
infanc
beg
question
whether
genet
predisposit
atopi
per
se
creat
suscept
asthmapromot
effect
viral
infect
exampl
subject
may
intrins
develop
excess
h
host
antivir
respons
ineffici
viral
elimin
whether
activ
express
atop
phenotyp
infanc
via
sensit
environment
allergen
requir
contrast
previou
studi
current
cohort
could
assess
spt
reactiv
employ
standard
criteria
broad
panel
allergen
month
month
en
rout
final
assess
outcom
age
year
demonstr
tabl
iii
stratif
studi
popul
basi
time
initi
express
atopi
reveal
associ
viral
infect
infanc
subsequ
develop
persist
wheez
current
asthma
year
restrict
subset
highrisk
children
manifest
sensit
first
year
life
moreov
associ
also
restrict
infect
spread
lower
respiratori
tract
suffici
intens
trigger
sever
symptom
infant
find
open
broad
interpret
first
line
bulk
current
prevail
opinion
field
earli
atop
sensit
sever
lri
infanc
could
indirect
marker
wheezi
viz
asthmat
phenotyp
per
se
without
play
direct
causal
role
argu
opinion
favor
direct
causal
relationship
effect
earli
wlri
earli
sensit
least
addit
relat
risk
subsequ
asthma
tabl
iii
see
refer
wlri
associ
transient
wheez
tabl
ii
febril
nonwheezi
lri
show
associ
subsequ
asthma
wlri
tabl
iii
suggest
infect
intens
infanc
key
factor
determin
level
risk
associ
individu
infect
oppos
whether
trigger
wheez
time
accordingli
suggest
altern
interpret
find
consist
model
recent
propos
asthma
etiolog
earli
life
model
contemporan
occurr
cycl
viralinduc
allergeninduc
inflamm
airway
period
rapid
lung
growth
remodel
infanc
interact
synergist
disrupt
underli
tissu
differenti
program
interact
result
deleteri
chang
ensu
respiratori
function
may
manifest
persist
wheez
andor
asthma
summari
data
current
studi
show
acut
sever
lri
caus
rhinoviru
rsv
first
year
life
import
contributor
current
asthma
persist
wheez
children
particularli
sensit
infanc
find
collect
suggest
develop
effect
strategi
shield
grow
airway
suscept
subject
inflamm
critic
window
period
infanc
may
valid
approach
longterm
asthma
prevent
moreov
given
possibl
viral
atopyassoci
inflamm
may
interact
synergist
drive
asthma
pathogenesi
effect
attenu
either
pathway
infant
may
suffici
achiev
signific
longterm
clinic
benefit
context
pertin
note
recent
public
indic
year
treatment
children
high
risk
asthma
inhal
corticosteroid
amelior
symptom
treatment
effect
lost
withdraw
treatment
argu
diseasemodifi
effect
earli
treatment
inhal
corticosteroid
howev
current
find
suggest
altern
strategi
use
broader
rang
treatment
protocol
includ
differ
class
antiinflammatori
drug
immunomodulatori
therapi
may
requir
assess
earli
intervent
result
diseas
modif
